Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0017 | 0.001 | 0.001 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0191 | 0.6193 | 0.6193 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0135 | 0.4197 | 0.4197 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0135 | 0.4197 | 0.6777 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0048 | 0.1105 | 0.1105 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0352 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.1105 | 0.1784 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0352 | 0.0352 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.1105 | 0.1105 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6193 | 0.6193 |
Echinococcus multilocularis | tar DNA binding protein | 0.0191 | 0.6193 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0048 | 0.1105 | 0.1105 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0352 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0017 | 0 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.0297 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6193 | 0.6193 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0352 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0191 | 0.6193 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0135 | 0.4197 | 0.4197 |
Onchocerca volvulus | 0.0164 | 0.5253 | 0.5 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0135 | 0.4197 | 0.6777 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.1105 | 0.1105 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0352 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0135 | 0.4197 | 0.6777 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6193 | 0.6193 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0135 | 0.4197 | 0.4197 |
Loa Loa (eye worm) | glutaminase 2 | 0.0297 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.1105 | 0.1784 |
Brugia malayi | MH2 domain containing protein | 0.013 | 0.4022 | 0.4022 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0352 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0152 | 0.4818 | 0.4818 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0048 | 0.1105 | 0.1784 |
Brugia malayi | hypothetical protein | 0.0164 | 0.5253 | 0.5253 |
Loa Loa (eye worm) | RNA binding protein | 0.0191 | 0.6193 | 0.6193 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.0352 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0048 | 0.1105 | 0.1784 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.1105 | 0.1105 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.3099 | 0.3099 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0135 | 0.4197 | 0.4197 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6193 | 0.6193 |
Loa Loa (eye worm) | TAR-binding protein | 0.0191 | 0.6193 | 0.6193 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0352 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.3099 | 0.3099 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.013 | 0.4022 | 0.4022 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.1105 | 0.1105 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.5617 | 0.5617 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0191 | 0.6193 | 0.6193 |
Loa Loa (eye worm) | glutaminase | 0.0297 | 1 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0048 | 0.1105 | 0.1784 |
Schistosoma mansoni | glutaminase | 0.0297 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0152 | 0.4818 | 0.4818 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0352 | 0.0352 |
Trichomonas vaginalis | glutaminase, putative | 0.0297 | 1 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0135 | 0.4197 | 0.6777 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.013 | 0.4022 | 0.4022 |
Brugia malayi | TAR-binding protein | 0.0191 | 0.6193 | 0.6193 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.1105 | 0.1105 |
Schistosoma mansoni | hypothetical protein | 0.0175 | 0.5617 | 0.5617 |
Echinococcus multilocularis | geminin | 0.0175 | 0.5617 | 0.9069 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0152 | 0.4818 | 0.4818 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0352 | 1 |
Echinococcus granulosus | geminin | 0.0175 | 0.5617 | 0.9069 |
Echinococcus granulosus | GPCR family 2 | 0.0048 | 0.1105 | 0.1784 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0048 | 0.1105 | 0.1105 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0104 | 0.3099 | 0.3099 |
Brugia malayi | RNA binding protein | 0.0191 | 0.6193 | 0.6193 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.5253 | 0.5253 |
Loa Loa (eye worm) | hypothetical protein | 0.0152 | 0.4818 | 0.4818 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0135 | 0.4197 | 0.4197 |
Schistosoma mansoni | tar DNA-binding protein | 0.0191 | 0.6193 | 0.6193 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 29.063 um | PUBCHEM_BIOASSAY: Secondary LDH Assay for Activators of Human Reticulocyte Pyruvate Kinase: for Probe SAR. (Class of assay: confirmatory) [Related pubchem assays: 2095, 1631 ] | ChEMBL. | No reference |
Potency (functional) | = 32.6092 um | PUBCHEM_BIOASSAY: Secondary assay for Inhibitors of Human Pyruvate Kinase M2 isoform. (Class of assay: confirmatory) [Related pubchem assays: 1634, 1631 ] | ChEMBL. | No reference |
Potency (functional) | = 32.6092 um | PUBCHEM_BIOASSAY: Secondary LDH Assay for Activators of Human Pyruvate Kinase M1 Isoform: for Probe SAR. (Class of assay: confirmatory) [Related pubchem assays: 1540, 2576, 2535, 2095, 1751, 2536, 2533, 2562, 2534, 1631 ] | ChEMBL. | No reference |
Potency (functional) | = 36.5881 um | PUBCHEM_BIOASSAY: Secondary LDH Assay for Activators of Human Liver Pyruvate Kinase: for Probe SAR. (Class of assay: confirmatory) [Related pubchem assays: 1540, 2576, 2535, 2095, 1751, 2536, 2533, 2562, 2534, 1631 ] | ChEMBL. | No reference |
Potency (functional) | 36.5881 uM | PUBCHEM_BIOASSAY: Secondary LDH Assay for Activators of Human Pyruvate Kinase M2 isoform: for Probe SAR. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.